Compare ARDX & WT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ARDX | WT |
|---|---|---|
| Founded | 2007 | 1985 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Bankers/Brokers/Service |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.7B |
| IPO Year | 2014 | N/A |
| Metric | ARDX | WT |
|---|---|---|
| Price | $7.32 | $15.74 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 10 | 3 |
| Target Price | $12.95 | ★ $17.08 |
| AVG Volume (30 Days) | ★ 5.9M | 5.3M |
| Earning Date | 02-19-2026 | 01-30-2026 |
| Dividend Yield | N/A | ★ 0.77% |
| EPS Growth | N/A | ★ 124.22 |
| EPS | N/A | ★ 0.75 |
| Revenue | $398,234,000.00 | ★ $493,753,000.00 |
| Revenue This Year | $22.44 | $24.95 |
| Revenue Next Year | $34.00 | $7.23 |
| P/E Ratio | ★ N/A | $20.67 |
| Revenue Growth | ★ 58.12 | 15.43 |
| 52 Week Low | $3.21 | $7.47 |
| 52 Week High | $8.40 | $17.09 |
| Indicator | ARDX | WT |
|---|---|---|
| Relative Strength Index (RSI) | 49.07 | 59.15 |
| Support Level | $6.92 | $15.42 |
| Resistance Level | $8.02 | $16.63 |
| Average True Range (ATR) | 0.41 | 0.59 |
| MACD | -0.13 | -0.14 |
| Stochastic Oscillator | 17.31 | 41.07 |
Ardelyx Inc is a biopharmaceutical company developing and commercialize, first-in-class medicines that meet unmet medical needs. It has developed a platform that enabled the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. It product Tenapanor, branded as IBSRELA, is used for the treatment of adults with IBS-C. Tenapanor, branded as XPHOZAH, is used to reduce serum phosphorus in adults with CKD on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy.
WisdomTree Inc is a financial innovator, offering a well-diversified suite of exchange-traded products (ETPs), models and solutions. It offers a broad range of ETFs and exchange-traded products (ETPs). The firm also engages in developing next-generation digital products and structures, including digital funds and tokenized assets, as well as its blockchain-native digital wallet, WisdomTree Prime. The Company conducts business under a single operating segment as an ETP sponsor and asset manager.